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ABSTRACT 
Background Basal cell carcinoma (BCC) is the most common skin cancer in the 
Caucasian population. Eighty percent of BCCs are located on the head and neck area. 
Clinically ill-defined BCCs often represent histologically aggressive subtypes, and 
they can have subtle subclinical extensions leading to recurrence and the need for re-
excisions. 
 
Objectives The aim of this pilot study was to test the feasibility of a hyperspectral 
imaging system (HIS) in vivo in delineating the preoperatively lateral margins of ill-
defined BCCs on the head and neck area. 
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Methods Ill-defined BCCs were assessed clinically with a dermatoscope, 
photographed, and imaged with HIS. This was followed by surgical procedures where 
the BCCs were excised at the clinical border and the marginal strip separately. HIS, 
with a 12 cm
2
 field of view and fast data processing, records a hyperspectral graph for 
every pixel in the imaged area, thus creating a data cube. With automated 
computational modelling, the spectral data is converted into localisation maps 
showing the tumour borders. Interpretation of these maps was compared to the 
histologically verified tumour borders. 
 
Results Sixteen BCCs were included. Of these cases, 10/16 were the aggressive 
subtype of BCC and 6/16 were nodular, superficial, or a mixed type. HIS delineated 
the lesions more accurately in 12/16 of the BCCs compared to the clinical evaluation 
(4/16 wider and 8/16 smaller by HIS). In 2/16 cases, the HIS-delineated lesion was 
wider without histopathological confirmation. In 2/16 cases, HIS did not detect the 
histopathologically confirmed subclinical extension.  
 
Conclusions HIS has the potential to be an easy and fast aid in the preoperative 
delineation of ill-defined BCCs, but further adjustment and larger studies are 
warranted for an optimal outcome.  
 
INTRODUCTION  
Basal cell carcinoma (BCC) is a locally destructive and rarely metastasising non-
melanoma skin cancer (NMSC), which comprises 40% of all cancers worldwide
1
. 
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Eighty percent of NMSCs are BCCs
2
. The incidence of BCC is as high as the 
incidence of all other cancers combined, and its incidence continues to increase, also 
affecting ever-younger populations
3-5
. BCC is causing a remarkable burden via 
healthcare costs, treatment capacity, and the morbidity of affected individuals
1,2,4
.  
Histologically, BCCs can be classified by their morphological growth pattern into 
indolent (nodular and superficial) or aggressive (micronodular, morpheaform, 
infiltrative, and metatypical – i.e. basosquamous) types6. In 27–43% of cases, a 
combination of different patterns – i.e. a mixed histology – exists6-8. The histological 
subtype affects the clinical choice of treatment and the prognosis
6
. A high risk of 
recurrence is associated most importantly with aggressive growth patterns along with 
location in high-risk anatomic areas (nose, ears, eyes, and periocular areas), clinically 
unclear visualisation of the border, immunosuppression, recurrence, and perineural 
involvement
9
. Clinically, BCCs are classified by visual assessment as either indolent 
(nodular, superficial) or ill-defined (aggressive subtypes)
9
. Roughly one out of five 
BCCs is the histologically verified aggressive subtype
6,10
. However, the proportion 
might be even higher. The accuracy of a punch biopsy in the interpretation of a mixed 
histology is 37%
11
. Moreover, in 39.1% of aggressive BBCs, the punch biopsy fails to 
identify the subtype correctly compared to the following excision, and 11–14.1% of 
any type of BCC shows an unsuspected aggressive component in the excision 
compared to the preceding punch biopsy
8,11
.  
 
The incidence of BCC is highest in the most sun-exposed anatomic locations
12
. Thus 
80% of BCCs – and most of the aggressive types – are located on the head and neck 
area
2,13
, where preserving the anatomy and function plays a major role. Surgery and, if 
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available, Mohs micrographic surgery (MMS) with a 100% margin control is the 
treatment of choice for high-risk BCCs
9
.  
Hyperspectral imaging is based on tissue chromophores (like melanin if present, 
haemoglobin, proteins, and water) affecting the absorption and scattering of emitted 
light, thus causing, together with autofluorescence, a unique spectral graph for 
different biological tissues
14
. A hyperspectral imaging system (HIS) has shown 
potential in the preoperative delineation of lentigo maligna
15
 and the detection of 
field-cancerised skin
16
. In this pilot study, the aim was to test the feasibility of HIS in 
the preoperative delineation of the lateral margins of ill-defined BCCs on the head 
and neck area. 
 
MATERIALS AND METHODS 
We followed the Declaration of Helsinki, and the Ethics Committee of the Tampere 
University Hospital District, Finland, approved our study protocol. All the recruited 
volunteering patients were informed orally and in writing, and they provided their 
written consent.  
 
Patients 
Twenty-three patients with 24 lesions were recruited prospectively between March 
2014 and March 2017 at the Department of Dermatology and Allergology at the 
Päijät-Häme Social and Health Care Group, Lahti, Finland. The inclusion criterion 
was a clinically assessed primary BCC with a visually ill-defined margin on the head 
and neck area, and which was later histologically confirmed to be a BCC. Eight BCCs 
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from seven patients were excluded: six because these were not treated according to 
the study protocol (3 represented only the superficial subtype and were treated with 
cryosurgery, and 3 were operated on without a separate circumferential marginal 
strip). Furthermore, one patient was excluded due to the imaging artefacts and one 
due to discrepancy in the histopathological statement (subclinical extension shown 
only in the preoperative biopsies and not in the separate margin strip).  
Thus, 16 patients (7 female and 9 male) with 16 lesions completed the study. The 
mean age of the patients was 77 years (range 59–91 years). Five patients displayed 
anamnestic skin phototype I, nine patients displayed skin phototype II, and two 
patients displayed skin phototype III. Thirteen patients had a previous history of skin 
malignancy or its precursor, and seven of them had multiple conditions (basal cell 
carcinoma n=12, actinic keratosis n=8, and melanoma n=2). None of the patients had 
received cytostatics or radiotherapy in the study areas or received phototherapy for 
any skin condition. One patient had received immunosuppressive treatments. 
 
Imaging processes 
All the lesions were initially evaluated clinically and with a dermatoscope (Dermlite® 
3GenCA, USA). They were photographed native with a digital camera (Canon Ixus 
115 HS, 12.1 megapixel or Canon Ixus 130, 14.1 megapixel) and with the 
dermatoscope linked to the digital camera. The hyperspectral imaging process was 
performed initially without drawing the clinically assessed tumour border, and then 
after marking the clinical borders on the skin. The prototype of HIS is described more 
detailed elsewhere 
15
. (In short, the VTT FPI VIS-VNIR Spectral Camera uses 
visible-to-near infrared light – i.e. wavelengths 500–900 nm based on a Fabry-Perot 
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interferometer – which enables the use of tuneable waveband selection. It has a large, 
12 cm
2
 field of view (FOV) with a spatial resolution of 6,400 pixels/cm
2
, where one 
pixel is approx. 125 µm, and an imaging depth of approx. 2 mm.)
 15
 The hyperspectral 
imaging took only seconds to capture the hyperspectral data cube, which thereafter 
was analysed computationally in 5–10 minutes.  
Data analysis 
The hyperspectral data cube is a three-dimensional data cube, where the x-axis and y-
axis are the dimensions on the skin surface, and the z-axis is the 70 layered 
hyperspectral images, where every layer is imaged on a narrow waveband. Every 
pixel on the skin’s surface has a unique hyperspectral graph – i.e. an end-member – 
from which the abundance maps are calculated based on mathematical modelling (see 
Fig.1).  
In this pilot study, we used mathematical modelling of linear mixture, as used in our 
previous studies
15,16
. These abundance maps were interpreted on site by the test-
readers (M.S., M.G., I.P. and N.N.). Additionally, we developed three diverse 
enhanced mathematical models to create more sensitive ways to characterise the 
visually ill-defined margins of BCCs. Finally, the mathematical models used for the 
results were 1) an inversion of linear mixture model using iterative Vertex Component 
Analysis – i.e. the linear mixture (the one used on site), 2) an inversion of linear 
mixture model from the estimated single scattering albedo (SSA) using iterative 
Vertex Component Analysis – i.e. the linear mixture with SSA, 3) a closed form 
chromophore-specific approximation for the estimated SSA – i.e. chromophore 
specific with SSA, and 4) a modified standard normal variate correction algorithm – 
i.e. a standard variate. All abundance maps from these four models were interpreted 
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by the same test-readers. A summarised technical and mathematical presentation of 
the imaging system used, the algorithms, and simulated results are presented in the 
supplementary material, S1. 
Each of the mathematical models used has advantages and disadvantages. The 
standard variate model is quite sensitive to all changes in spectra that differ from the 
mean spectra of the imaged area. When there is either a lot of normal skin or an ill-
defined BCC, the standard variate model will distinguish the areas well. The linear 
mixture and linear mixture with SSA both capture changes in the concentration of 
skin chromophores. The chromophore specific with SSA is sensitive to skin scattering 
and absorption. The results from calculations with the linear mixture, the linear 
mixture with SSA, and the chromophore specific with SSA models can be used to 
simulate an imaged spectral cube. The simulated cube is a characterisation of the 
originally acquired image presented in the form of an abundance map for 
interpretation.  
 
Surgical procedures and the histopathological sampling 
After the imaging and analysis processes, and if the patient did not have an 
appointment for an operation on the same day, we took biopsies from the lesions and 
the areas where the HIS imaging indicated the BCC may be spreading. For all cases, 
we used a special operation technique to verify whether a subclinical extension was 
detected by HIS (see Fig.1). This included an initial excision of the tumour from the 
clinically and dermatoscopically detected border followed by a separately operated 2 
mm circumferential marginal strip, both with orientation marks. The circumferential 
strip allowed us to evaluate whether there was a subclinical extension in the marginal 
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area. If a free margin was found in the separately excised tumour specimen, this 
allowed us to evaluate if the BCC was smaller than the clinical evaluation with 
dermatoscopy. All the samples were orientated, fixed in 10% formalin, embedded in 
paraffin, and cut into 3 µm thick slices, which were stained with haematoxylin and 
eosin and, if necessary, with CK-PAN staining for the evaluation of perineural 
involvement. The tumour specimens were sectioned using the normal “bread-loaf” 
technique. The circumferential strips were sectioned closely in vertical slices. The 
histopathological samples were analysed by an experienced dermatopathologist 
blinded to the HIS outcome. If the circumferential marginal strip was BCC-positive, a 
re-excision was performed. 
 
RESULTS 
The histopathological subtypes of the 16 included BCCs are shown in Table 1. 10/16 
BCCs represented the aggressive subtype (infiltrative, infiltrative with perineural 
invasion, morpheaform, or micronodular features) in the final excision. In 6/16 BCCs 
the subtype was nodular, superficial, or a mixed histology of these two in the final 
excision, even though clinically all the included lesions were ill defined.  
In 12/16 cases, HIS was capable of delineating the BCCs more accurately than the 
conventional clinical evaluation by the naked eye and with a dermatoscope. HIS-
delineated lesions were wider in 4/16 of the BCCs (see Fig.2), and in 8/16 BCCs the 
lesions were delineated to be smaller than the clinical evaluation. In 2/16 cases, the 
HIS-delineated lesion was wider but could not be confirmed histopathologically (false 
positives). In 2/16 cases, HIS did not detect the histopathologically confirmed BCC in 
the circumferential strip (false negatives).  
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The results were quite similar in the four different mathematical models. If three out 
of four models showed similar tumour borders, those were regarded as the 
HIS-defined borders (see Table 1). However, it is still unclear which model is best for 
the imaging of BCC. 
 
DISCUSSION 
This study shows that HIS is feasible in detecting the borders of ill-defined BCCs, but 
further development work is needed to determine the optimal model for data 
processing. 
To our knowledge, there are no earlier studies on delineating BCC margins using 
hyperspectral imaging technology.  
Other non-invasive imaging techniques for delineating the lateral margins of BCCs 
include dermatoscopy, reflectance confocal microscopy (RCM), and optical 
coherence tomography (OCT)/high-definition optical coherence tomography (HD-
OCT). In clinical practice, dermatoscopy is the most widely used for the detection of 
lateral margins, although its use preoperatively has not reduced the excision stages in 
MMS, and thus evidence of its accuracy is lacking
17
. It has been previously shown 
that preoperative in vivo use of RCM and OCT can reduce the number of excision 
stages in the MMS of BCCs
17
. 
The advantages of HIS compared to the previously studied imaging techniques in the 
preoperative assessment of the lateral surgical margin are the following: i) adjustable 
FOV up to a maximum of 12 m
2
 in HIS captured and processed in 5–10 min 
compared to 1 cm
2
 (with mosaicking) in RCM captured and processed in 2 min
18
, and 
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6x6 mm (0.36 cm
2
) in OCT, where 5x5 mm is captured and processed in 40 s
19
; ii) 
imaging depth of approx. 2 mm for HIS compared to 200 µm for RCM
17
 and 0.2–2.5 
mm for OCT, though one should note that the higher resolution is compromised by 
the penetration depth
19
; and iii) interpretation of HIS images is quick, easy to learn 
with a little experience, and does not require histological knowledge, unlike HD-OCT 
and RCM
17,19
. It seems that the interpretation of HIS images can be straightforward, 
but currently in some cases more combined information is needed from different 
models to conclude the interpretation, and thus further development of HIS is 
warranted.  
Our result for 4/16 BCCs revealed that subclinical extension by HIS is quite similar to 
RCM in the preoperative in vivo assessment of the margins, as in Venturini et al.’s 
study, RCM found subclinical extension in 3/10 cases compared to the 
dermatoscopically assessed margins prior to excision
20
. OCT found the subclinical 
extension of BCC in 11/52 cases compared to clinical evaluation by a Mohs 
surgeon
21
. Wang et al.
 21
 had a 100% evaluation of the margins in MMS excision 
compared to our design with vertical sections, which is clearly a limitation in our 
study. Furthermore, OCT delineated the lateral margins to be smaller by 1.4 +/-1.3 
mm than the clinical evaluation
21
. HIS delineated the lesion as being smaller in 8/16 
cases.  
In addition, high frequency ultrasound (HFUS) and fluorescence diagnosis have 
earlier been studied for the in vivo preoperative delineation of BCC. In lateral margin 
delineation, ultrasound has a low correlation compared to histopathology
22
. The 
subclinical extensions of the infiltrative and micronodular subtypes of BCC in 
particular are less likely to be detected by HFUS
23
. In deep margin assessment, the 
correlation using HFUS is intermediate
22
, and in facial BCCs, there is even a good 
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correlation for the deep margin with histopathology
24
. HFUS has the advantage of 
showing underlying structures like cartilage and bone
24
. In the fluorescence diagnosis 
of facial BCCs, the exogenic fluorescence diagnosis has no benefit in margin 
assessment compared to clinical evaluation in high risk areas (though most of the 
BCCs were nodular in this study)
 25
, but in aggressive types bispectral fluorescence 
imaging (using autogenic and exogenic fluorescence) had some potential in 
delineating the margins of BCC, with a 42% agreement in lateral margin assessment 
compared to the histopathology of MMS26.  
A limitation of HIS is its poorer resolution compared to OCT and RCM. In this study, 
HIS was not used to evaluate the deep margin, which in the future might be possible 
with further developments given the approx. 2 mm penetration depth of HIS. 
However, the assessment of deep margins is also limited with RCM and HD-OCT
17
. 
Artefacts in HIS abundance maps can be caused by an uneven imaging surface – i.e. 
round and sharp forms in the imaging area, and thus one case locating on nose was 
excluded with low quality in the abundance maps for interpretation. With further 
developments of HIS, it might be possible to handle these artefacts better. Additional 
pathological findings (i.e. actinic keratoses, etc.) in the imaging area might also be 
confounding factors in the interpretation of the HIS abundance maps, and thus further 
development work with HIS is needed. The limitations in our pilot study design were 
the small number of the cases, and thus these results are preliminary. This study was 
not performed to distinguish BCCs from other lesions on sun-damaged skin, but 
rather to visualise the borders of the lesions. Thus, larger studies are warranted in the 
future. 
Subclinical extension in aggressive BCCs can consist of cords with a thickness of a 
few cells
6
. Thus, in the future it would be interesting to repeat this study design by 
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assessing 100% of the margin and comparing the results to MMS. At the clinic where 
patients were recruited, MMS is not available, and thus we used the presented 
operation technique. Compared to MMS, in our method the separate circumferential 
strip was not assessed with a 100% margin control. In one true positive case, we were 
able to confirm subclinical extension of the marginal strip after additional histological 
sectioning based on the suspected subclinical extension in the HIS abundance maps. 
However, additional sectioning failed to reveal the subclinical extension in the two 
other false positive cases. It can be speculated that MMS with a 100% margin control 
would have revealed the histological extension in these false positive cases. 
It would be interesting to investigate if HIS could be useful in MMS by reducing the 
number of stages by defining the margins preoperatively more accurately than the 
clinical evaluation, and by being faster than RCM. HIS might be also useful in 
reducing the number of re-excisions by more accurate preoperative assessment in 
intermediate- or low-risk anatomic locations, and also in high-risk areas if MMS is 
not available. After MMS, primary BCCs have a 4.4% recurrence and recurrent BCCs 
have a 3.9% recurrence in the 10-year follow-up; after traditional excision, the 
corresponding rates are 12.2% and 13.5%
27
. In traditional excision, the recurrence 
rates varies according to the width of the surgical margin, where a 2, 3, 4 or 5 mm 
announced negative margin has a recurrence rate of 3.96, 2.56, 1.62 and 0.39% 
respectively; if a positive margin is announced, the overall recurrence is 27%
28
. In the 
future with HIS, it might be possible to save tissues in cosmetically sensitive areas. 
With the increasing incidence of BCCs, there is a need for new technologies to make 
the treatment of BCC less time-consuming and more cost-effective. With preliminary 
results of 12/16 more precisely delineated lesions and 4/16 revealed subclinical 
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extensions, the HIS has the potential to be a clinical aid in treatment of ill-defined 
BCCs in the cosmetically sensitive areas of the head and neck region. 
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FIGURES AND LEGENDS 
 
 
Fig. 1 A) Hyperspectral imaging process and B) operation technique to verify the 
subclinical extension detected by HIS. 
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Fig. 2 Example patient with BCC delineated wider by HIS. Histologically, there was a 
nodular, superficial, micronodular, and infiltrative BCC, with perineural invasion, 
which showed subclinical micronodular growth in the marginal strip shown by HIS 
(arrows). A) Clinical picture, B) final excision with our operation technique, C) 
dermatoscopy image, D1) histological image from the main tumour area with the 
different aggressive growth patterns D2–D3) histological image, where the subclinical 
extension of BCC was detected in the separate marginal strip (D2 lower arrow and D3 
upper arrow). HIS abundance maps marking the clinically and dermatoscopically 
assessed tumour border on the skin (arrows pointing the subclinical extension 
detected by HIS): E) linear mixture F) linear mixture with single scattering albedo 
(SSA), G) chromophore specific with SSA H) standard variate. 
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TABLES  
Table 1. Histopathological analyses of the BCCs, anatomic location of the lesion, interpretation of the mathematical models, and the HIS 
outcome compared to clinical evaluation. 
esion 
Anatomic 
location of 
the lesion 
BCC subtype in 
the biopsies BCC subtype in the final excision 
BCC subtype in 
the separate 
circumferential 
strip 
Additional 
histopathological 
findings 
Linear 
mixture 
model 
Enhanced 
linear 
mixture 
model 
Chromo-
phore 
specific 
model 
Mean 
value 
model 
HIS outcome compared to the 
clinical assessment, and 
confirmed histologically 
1 right cheek  superficial, nodular, micronodular sun damaged skin + + + + false pos.* 
2 tip of nose  superficial, nodular sun damaged skin - - - 0 smaller** 
3 preaurically 
on right 
cheek 
nodulocystic superficial, nodular, micronodular superficial solar lentigo + + + + wider*** 
4 tip of nose  superficial, nodular, micronodular,  
infiltrative, basosquamous 
sun damaged skin - - - 0 smaller 
5 lateral to 
nasolabial 
fold on right 
cheek 
nodular nodular  sun damaged skin - - - - smaller 
6 left cheek nodular, 
micronodular 
nodular, micronodular sun damaged skin - - - - smaller 
7 forehead nodular, 
micronodular 
superficial, nodular, micronodular, 
infiltrative with perineural invasion 
micronodular actinic keratoses + + + + wider 
8 left auricle superficial, 
nodular 
superficial, nodular sun damaged skin - - - 0 smaller 
9 right temple nodular, 
micronodular, 
sclerotic 
nodular, micronodular, infiltrative 
with perineural invasion 
micronodular solar lentigo + + + 0 wider 
10 left auricle superficial, 
nodular 
nodular, micronodular, infiltrative micronodular sun damaged skin = = = 0 false neg. **** 
11 neck, behind left ear nodular  actinic kertoses,  
solar lentigo 
- - - - smaller 
12 left cheek nodular superficial, nodular sun damaged skin, solar 
lentigo 
+ + + + false pos. 
13 left cheek nodular cicatrix  eczema - - - - smaller 
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14 right ala of 
nose 
nodular nodular, micronodular nodular, 
micronodular 
actinic keratoses = = = = false neg. 
15 right temple superficial superficial, nodular, micronodular,  
infiltrative with perineural invasion 
sun damaged skin, ulcer - - - -  smaller 
16 forehead nodular, 
infiltrative 
nodular, micronodular nodular, 
micronodular 
sun damaged skin 0 + + + wider 
(+) interpret wider in the abundance maps 
 
(-) interpret smaller in the abundance maps 
(0) too much of artefact for interpretation 
(=) interpreted as same borders as than visually assessed (the margins announced in the tumor specimen were from 0 to 0,9 mm) 
* HIS delineated the lesion wider than clinical assessment, but this wasn't supported by histopathology
** HIS delineated the lesion smaller than clinical assessment, and histopathology supported this 
*** HIS delineated the lesion wider than the clinical assessment, and the histopathology supported this 
**** HIS showed no suspicious for subclinical extension, but in the histopathology there was BCC in the circumferential strip 
 
Supplementary material for article “Hyperspectral Imaging System in the Delineation 
of Ill-defined Basal Cell Carcinomas: A Pilot Study” 
Appendix S1: Summarised description of the hyperspectral imaging system and the 
mathematical models 
The studied handheld hyperspectral camera (VTT FPI VIS-VNIR Spectral Camera) 
was developed with the VTT Technical Research Centre of Finland; it is introduced in 
detail by Saari et al.29 The camera uses visible-to-near infrared light (wavelengths 
500–900 nm) based on a piezoactuated Fabry-Perot interferometer (FPI) with an 
adjustable air gap, one or two CMOS RGB colour sensors (MT009V022), basic 
camera objectives, microscope lenses, filters, and a dichroic beam splitter, which 
divides the light beam coming from the camera’s light source (ring light around the 
lens system, a halogen based fibre-optic illuminator; Dolan-Jenner Fibre-Lite DC 
950) into visible light and very near infrared light.  
The FPI consists of reflecting mirrors in a cavity, and the air gap between these 
mirrors is adjustable. By tuning this air gap, it is possible to record different 
wavelengths29. The FPI reflects three wavelength peaks at one air gap width, and by 
changing the width of the gap, it is possible to record another set of three different 
wavelengths29. Changing the air gap width takes < 2 ms29. Thus, it is possible to 
receive spectral information at 70 different wavelengths very quickly.  
At the same time as the spectral information is gathered, the camera records a 
traditional 2D image with a resolution of 240x320 pixels, which are approx. 125 µm 
in width. Every pixel has a unique spectral graph that forms the third dimension of the 
spectral data cube (see Fig. 1A). Use of this data cube enables spectral mapping, i.e. 
the localisation of the spectral information in the imaged area. With the 500–900 nm 
wavelengths, it is possible to reach approx. up to 2 mm penetration depth, with shorter 
wavelengths reaching more superficial depths and the wider wavelengths penetrating 
the deeper parts of the skin.  
The part of the camera system touching the object (i.e. the patient’s skin) is a dark 
cover tube that is available in varying sizes (range 2.5–12 cm2). The tube removes 
background light and defines the field of view (FOV). The maximum FOV is thus 
12 cm2. The cover tubes are selected according to the size of the lesion, and smaller 
tubes enable the flattening of uneven surfaces, such as the nose or ear.  
The spectral data cube – i.e. the recorded reflectance gathered by the colour sensors in 
the ENVI standard data format – is transferred to a computer via a USB2 port29. The 
different wavelengths are recorded in the different proportions of the RGB sensor 
output. This data is converted to reflectance X, in which Xλ = (Iλ – Idark) / 
(Iλ,white - Idark), where λ is all recorded wavelengths, Iλ is the recorded raw digital 
image, Iλ,white is the recorded white reference, and Idark is the dark current of the colour 
sensor.  
The huge amount of information imaged in the spectral cube can be represented 
numerically, and thereafter, it is possible to apply an algorithm, i.e. a mathematical 
model with computational calculations. With the mathematical modelling, it is 
possible to calculate an end-member (i.e. pure spectrum) from the spectral graphs of 
every pixel in the image (see Fig. 1A). These end-members are converted for 
interpretation to abundance maps, which show the localisation of the end-member 
spectra in the image. Every mathematical model is an assumption of the real world, 
and by these assumptions, we are able to visualise the information on the spectral 
dimension of the data cube. 
Our mathematical models used the information on tissue optical properties and the 
coefficients of different parameters available in the literature30. The main properties 
affecting the tissue optics and reflectance are absorption and scattering. Both 
absorption and scattering vary based on the chromophores (i.e. melanin, water, 
haemoglobin, etc.) in different tissues30. Interestingly, it is possible to numerically 
represent the three layers of the skin (epidermis, dermis, and subcutaneous fat) as a 
combination of the absorption and scattering properties of the different 
chromophores30. 
The four numerical methods used in this study were 1) an inversion of the linear 
mixture model using iterative Vertex Component Analysis – i.e. the linear mixture, 2) 
an inversion of the linear mixture model from the estimated single scattering albedo 
(SSA) using iterative Vertex Component Analysis – i.e. the linear mixture with SSA, 
3) a closed form chromophore-specific approximation for the estimated SSA – i.e. 
chromophore specific with SSA, and 4) a modified standard normal variate correction 
algorithm – i.e. a standard variate. 
1) Linear mixture 
The linear mixture algorithm assumes that the spectra in the imaged cube are a linear 
mixture of some limited number of characterised spectra, which are named 
end-members. The linear mixture of end-members can be expressed in matrix form 
following 𝑋𝑋 = 𝑀𝑀𝑀𝑀, where 𝑋𝑋 is the recorded spectral data, 𝑀𝑀 is the mixing matrix, and 
𝑀𝑀 are the end-members. The linear mixture model uses vertex component analysis 
(VCA) 31 to define the end-members. The mixing matrix describes proportion of 
end-members in every pixel. To calculate computationally the inversion of the mixing 
matrix, filter vector analysis (FVA) 32 was used. Next, 𝑀𝑀 and 𝑀𝑀 are solved. This step is 
iteratively repeated several times to determine the right number of end-members. 
Selection of the right number of end-members is arrived at in order to minimise min
𝑘𝑘
�𝑋𝑋 − 𝑋𝑋��
𝐹𝐹𝐹𝐹𝐹𝐹
, where k is the number of end-members, which usually varies 
between 2 and 6 because VCA usually detects 2–4 end-members on the skin with 
malignancy based on experience. With this model, we assume the end-members of the 
healthy skin and tumour area differ from each other. 
2) Linear mixture with SSA 
The skin’s reflectance spectra is not actually linearly mixed. The reflectance of the 
skin is actually a non-linear mixture of the different chromophores’ absorbance and 
scattering properties. With a rough estimate, the reflectance spectra can be converted 
into a single scattering albedo (SSA). SSA is calculated based on the scattering 
coefficient and total absorption coefficient. SSAs are linearly mixed. After this 
conversion, we apply VCA31 to define the end-members. Thus, the non-linear “real 
world” is converted to a more linear form, enabling the use of VCA. With this model, 
we assume that the calculated end-members of the healthy skin and the tumour area 
might more accurately represent the “real world”. 
3) Chromophore specific with SSA 
In this model, SSA is used to describe the recorded reflectance upon which FVA32 is 
applied to solve the different proportion of chromophores. The coefficients of 
different chromophores are multiplied by the proportion of the chromophores. Thus, 
we create reconstructed data, in which we can weigh a certain chromophore’s 
end-member in the abundance map. In doing so, we assume that the proportion of 
certain chromophores differs in the healthy skin and the tumour area. In the 
chromophore-specific model, we produce the maps with oxyhaemoglobin 
concentration, deoxygenated haemoglobin concentration, total blood concentration, 
oxygen saturation, mean scattering of simulation, mean absorption of simulation, 
melanin concentration, and baseline concentration. For example, the tumour uses 
more oxygen, and in the abundance map of “deoxygenated haemoglobin 
concentration”, we can see the difference the between the tumour area and the healthy 
skin. Thus, we are able to visualize a certain chromophore in the abundance map. 
4) Standard variate 
The standard variate model differs from the three models presented above. It has a 
statistical background, and in essence, it compares how the spectra differ from the 
mean spectra. The standard variate algorithm reduces spectral noise and eliminates the 
background effect33. This means that if there are many similar spectra in the imaged 
cube, the standard variate model will characterise the differences in the spectra 
without the homogenous background information. Originally, standard variate 
algorithm was developed for the single point spectroscopy. For our purpose we added 
some modifications so that it gives us mapping in spatial domain, which separates two 
areas from image, which refers to background (healthy tissue) and anomalous area 
(tumorous tissue).  
 
 
